Smoking Relapse-Prevention Intervention for Cancer Patients

NACompletedINTERVENTIONAL
Enrollment

441

Participants

Timeline

Start Date

January 4, 2012

Primary Completion Date

May 15, 2015

Study Completion Date

November 18, 2020

Conditions
Smoking Cessation
Interventions
BEHAVIORAL

Usual Care

Standard care includes routine assessment of smoking behavior and brief clinical intervention. Smoking counseling for all participants in the current study will be completed by a Certified Tobacco Treatment Specialist consisting consists of brief counseling (\<15 minutes) based on the 5 A's Clinical Practice Guidelines; Ask about tobacco use, Advise to quit, Assess willingness to make a quit attempt, Assist in quit attempt, Arrange for follow-up (Fiore et al., 2008). Patients receive information for local and state smoking resources (e.g., Quitline), pharmacotherapy options, and if interested, assistance with obtaining a prescription for pharmacotherapy. Follow-up with patients occurs at 2-weeks, only among those who are prescribed smoking medications (i.e., Varenicline, Bupropion).

BEHAVIORAL

Smoking Relapse Prevention for Cancer Patients (SRP-CaP)

The proposed multimodal intervention consists of a series of easy-to-read relapse prevention booklets (Forever Free) that have shown to be efficacious with a general smoking population (Brandon et al., 2000; 2004), and digital video disk (DVD) customized to the needs of cancer patients (to be developed in Year One).

Trial Locations (1)

33612

H. Lee Moffitt Cancer Center and Research Institute, Tampa

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

H. Lee Moffitt Cancer Center and Research Institute

OTHER

NCT01630161 - Smoking Relapse-Prevention Intervention for Cancer Patients | Biotech Hunter | Biotech Hunter